Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients

Abstract Background The real‐world outcomes of edoxaban treatment in patients with atrial fibrillation (AF) were analyzed in the ETNA‐AF (Edoxaban Treatment in Routine Clinical Practice) study involving data from multiple regional registries. This report addresses effectiveness and safety of edoxaba...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Eue‐Keun Choi, Jong‐Il Choi, Hyoung‐Seob Park, Gyo‐Seung Hwang, Boyoung Joung, Jong‐Youn Kim, Dae‐Hyeok Kim, Dong Gu Shin, Hyung Wook Park
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2023-08-01
Ráidu:	Journal of Arrhythmia
Fáttát:	major bleeding non‐vitamin K antagonist oral anticoagulants real‐world registry stroke prevention
Liŋkkat:	https://doi.org/10.1002/joa3.12878
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!